These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17385073)

  • 1. Hypericin photoactivation triggers down-regulation of matrix metalloproteinase-9 expression in well-differentiated human nasopharyngeal cancer cells.
    Du HY; Olivo M; Mahendran R; Huang Q; Shen HM; Ong CN; Bay BH
    Cell Mol Life Sci; 2007 Apr; 64(7-8):979-88. PubMed ID: 17385073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoactivation of hypericin down-regulates glutathione S-transferase activity in nasopharyngeal cancer cells.
    Du HY; Olivo M; Tan BK; Bay BH
    Cancer Lett; 2004 Apr; 207(2):175-81. PubMed ID: 15072826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Matrix metalloproteinase-1 in nasopharyngeal cancer cells by photoactivation of hypericin.
    Du H; Olivo M; Mahendran R; Bay BH
    Int J Oncol; 2004 Mar; 24(3):657-62. PubMed ID: 14767550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypericin-mediated photodynamic therapy elicits differential interleukin-6 response in nasopharyngeal cancer.
    Du H; Bay BH; Mahendran R; Olivo M
    Cancer Lett; 2006 Apr; 235(2):202-8. PubMed ID: 15935550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Y-Box binding protein-1 following hypericin-mediated photodynamic therapy in well-differentiated nasopharyngeal cancer in vivo.
    Du HY; Olivo M; Chen YJ; Yip G; Tan PH; Matsumoto K; Tsujimoto M; Bay BH
    Int J Mol Med; 2005 Nov; 16(5):865-8. PubMed ID: 16211256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypericin-mediated photodynamic therapy induces lipid peroxidation and necrosis in nasopharyngeal cancer.
    Du HY; Olivo M; Tan BK; Bay BH
    Int J Oncol; 2003 Nov; 23(5):1401-5. PubMed ID: 14532982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model.
    Du HY; Bay BH; Olivo M
    Int J Oncol; 2003 May; 22(5):1019-24. PubMed ID: 12684667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
    Bhuvaneswari R; Gan YY; Yee KK; Soo KC; Olivo M
    Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-angiogenic effects of Hypericin-photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma.
    Yee KK; Soo KC; Olivo M
    Int J Mol Med; 2005 Dec; 16(6):993-1002. PubMed ID: 16273277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential up-regulation of metallothionein isoforms in well-differentiated nasopharyngeal cancer cells in vitro by photoactivated hypericin.
    Du HY; Li Y; Olivo M; Yip GW; Bay BH
    Oncol Rep; 2006 Dec; 16(6):1397-402. PubMed ID: 17089067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypericin lights up the way for the potential treatment of nasopharyngeal cancer by photodynamic therapy.
    Olivo M; Du HY; Bay BH
    Curr Clin Pharmacol; 2006 Sep; 1(3):217-22. PubMed ID: 18666746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous expression of interleukin-8 and interleukin-10 in nasopharyngeal carcinoma cells and the effect of photodynamic therapy.
    Du H; Bay BH; Mahendran R; Olivo M
    Int J Mol Med; 2002 Jul; 10(1):73-6. PubMed ID: 12060853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of p38 MAPKs in hypericin photodynamic therapy-induced apoptosis of nasopharyngeal carcinoma cells.
    Chan PS; Koon HK; Wu ZG; Wong RN; Lung ML; Chang CK; Mak NK
    Photochem Photobiol; 2009; 85(5):1207-17. PubMed ID: 19496992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models.
    Zhou Q; Olivo M; Lye KY; Moore S; Sharma A; Chowbay B
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):569-77. PubMed ID: 16001166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells.
    Hendrickx N; Volanti C; Moens U; Seternes OM; de Witte P; Vandenheede JR; Piette J; Agostinis P
    J Biol Chem; 2003 Dec; 278(52):52231-9. PubMed ID: 14557269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and molecular mechanisms of photodynamic hypericin therapy for nasopharyngeal carcinoma cells.
    Wang X; Guo Y; Yang S; Wang C; Fu X; Wang J; Mao Y; Zhang J; Li Y
    J Pharmacol Exp Ther; 2010 Sep; 334(3):847-53. PubMed ID: 20551295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation.
    Cortez DM; Feldman MD; Mummidi S; Valente AJ; Steffensen B; Vincenti M; Barnes JL; Chandrasekar B
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3356-65. PubMed ID: 17921324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypericin-mediated photodynamic therapy inhibits growth of colorectal cancer cells via inducing S phase cell cycle arrest and apoptosis.
    Hu J; Song J; Tang Z; Wei S; Chen L; Zhou R
    Eur J Pharmacol; 2021 Jun; 900():174071. PubMed ID: 33811836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT.
    Thong PS; Watt F; Ren MQ; Tan PH; Soo KC; Olivo M
    J Photochem Photobiol B; 2006 Jan; 82(1):1-8. PubMed ID: 16203156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction of apoptosis and suppression of viral transcription.
    Xu L; Zhang X; Cheng W; Wang Y; Yi K; Wang Z; Zhang Y; Shao L; Zhao T
    Retrovirology; 2019 Feb; 16(1):5. PubMed ID: 30782173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.